Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 2.7% in First Three Quarters of 2023

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 1.9 billion yuan in the first three quarters of 2023, down 2.7% year-on-year.

Meanwhile, the company posted 114.4 billion yuan in revenue, up 11.1% year-on-year.

At the end of the reporting period, it had 92.9 billion yuan in total assets and 64.6 billion yuan in total liabilities, with a liability-to-asset ratio of 69.6%.